Literature DB >> 23169882

Ocular surface extracellular DNA and nuclease activity imbalance: a new paradigm for inflammation in dry eye disease.

Snehal Sonawane1, Vishakha Khanolkar, Abed Namavari, Shweta Chaudhary, Sonal Gandhi, Sapna Tibrewal, Sarmad H Jassim, Brittany Shaheen, Joelle Hallak, John H Horner, Martin Newcomb, Joy Sarkar, Sandeep Jain.   

Abstract

PURPOSE: We determined whether nucleases are deficient in the tear fluid of dry eye disease (DED) patients, and whether this causes extracellular DNA (eDNA) and neutrophil extracellular trap (NET) accumulation in the precorneal tear film, thus causing ocular surface inflammation.
METHODS: Exfoliated cells adhered to Schirmer test strips were collected on glass slides, and immunofluorescence confocal microscopy was used to evaluate neutrophils, eDNA, NETs, and their molecular components. Similar experiments were performed with mucoid films collected from the inferior conjunctival fornix or bulbar conjunctiva. We used quantitative PCR to evaluate eDNA signaling pathways and inflammatory cytokine expression. We also determined the amount of ocular surface eDNA and evaluated tear fluid nuclease activity.
RESULTS: eDNA, NETs, and neutrophils were present on the ocular surface in DED patients and abundant in mucoid films. NETs consisted of eDNA, histones, cathelicidin, and neutrophil elastase. Tear fluid nuclease activity was decreased significantly in DED patients, whereas the amount of eDNA on the ocular surface was increased significantly. Expression of genes downstream of eDNA signaling, such as TLR9, MyD88, and type I interferon, as well as the inflammatory cytokines interleukin-6 and tumor necrosis factor-α, was significantly increased in DED patients.
CONCLUSIONS: Extracellular DNA production and clearance mechanisms are dysregulated in DED. Nuclease deficiency in tear fluid allows eDNA and NETs to accumulate in precorneal tear film, and results in ocular surface inflammation. These findings point to novel therapeutic interventions in severe DED based on clearance of eDNA, NETs, and other molecular components from the ocular surface.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23169882      PMCID: PMC3525138          DOI: 10.1167/iovs.12-10430

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  61 in total

1.  Kinetics of corneal epithelium turnover in vivo. Studies of lovastatin.

Authors:  R J Cenedella; C R Fleschner
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-10       Impact factor: 4.799

Review 2.  Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.

Authors:  Stefano Barabino; Yihe Chen; Sunil Chauhan; Reza Dana
Journal:  Prog Retin Eye Res       Date:  2012-03-08       Impact factor: 21.198

3.  Ocular manifestation of systemic lupus erythematosus.

Authors:  Rawhya R El-Shereef; Ahmad Shawkat Mohamed; Lamiaa Hamdy
Journal:  Rheumatol Int       Date:  2011-12-28       Impact factor: 2.631

4.  Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation.

Authors:  L Zheng; E H Walters; C Ward; N Wang; B Orsida; H Whitford; T J Williams; T Kotsimbos; G I Snell
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

5.  Autologous serum eye drops for the treatment of dry eye diseases.

Authors:  Takashi Kojima; Akihiro Higuchi; Eiki Goto; Yukihiro Matsumoto; Murat Dogru; Kazuo Tsubota
Journal:  Cornea       Date:  2008-09       Impact factor: 2.651

Review 6.  Inflammatory clearance of apoptotic remnants in systemic lupus erythematosus (SLE).

Authors:  C Janko; C Schorn; G E Grossmayer; B Frey; M Herrmann; U S Gaipl; L E Munoz
Journal:  Autoimmun Rev       Date:  2008-08-12       Impact factor: 9.754

7.  Release of membrane-associated mucins from ocular surface epithelia.

Authors:  Timothy D Blalock; Sandra J Spurr-Michaud; Ann S Tisdale; Ilene K Gipson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05       Impact factor: 4.799

8.  Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome.

Authors:  Jacques-Eric Gottenberg; Nicolas Cagnard; Carlo Lucchesi; Franck Letourneur; Sylvie Mistou; Thierry Lazure; Sebastien Jacques; Nathalie Ba; Marc Ittah; Christine Lepajolec; Marc Labetoulle; Marc Ardizzone; Jean Sibilia; Catherine Fournier; Gilles Chiocchia; Xavier Mariette
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

9.  The formyl peptide receptor like-1 and scavenger receptor MARCO are involved in glial cell activation in bacterial meningitis.

Authors:  Benedikt J Braun; Alexander Slowik; Stephen L Leib; Ralph Lucius; Deike Varoga; Christoph J Wruck; Sandra Jansen; Rainer Podschun; Thomas Pufe; Lars-Ove Brandenburg
Journal:  J Neuroinflammation       Date:  2011-02-07       Impact factor: 8.322

10.  Novel cell death program leads to neutrophil extracellular traps.

Authors:  Tobias A Fuchs; Ulrike Abed; Christian Goosmann; Robert Hurwitz; Ilka Schulze; Volker Wahn; Yvette Weinrauch; Volker Brinkmann; Arturo Zychlinsky
Journal:  J Cell Biol       Date:  2007-01-08       Impact factor: 10.539

View more
  32 in total

1.  Neutrophil extracellular traps (NETs) contribute to pathological changes of ocular graft-vs.-host disease (oGVHD) dry eye: Implications for novel biomarkers and therapeutic strategies.

Authors:  Seungwon An; Ilangovan Raju; Bayasgalan Surenkhuu; Ji-Eun Kwon; Shilpa Gulati; Muge Karaman; Anubhav Pradeep; Satyabrata Sinha; Christine Mun; Sandeep Jain
Journal:  Ocul Surf       Date:  2019-04-06       Impact factor: 5.033

Review 2.  Lacritin and the tear proteome as natural replacement therapy for dry eye.

Authors:  Roy Karnati; Diane E Laurie; Gordon W Laurie
Journal:  Exp Eye Res       Date:  2013-06-12       Impact factor: 3.467

3.  Single Nucleotide Polymorphisms in the BDNF, VDR, and DNASE 1 Genes in Dry Eye Disease Patients: A Case-Control Study.

Authors:  Joelle A Hallak; Sapna Tibrewal; Neil Mohindra; Xiaoyi Gao; Sandeep Jain
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

4.  Hyperosmolar stress induces neutrophil extracellular trap formation: implications for dry eye disease.

Authors:  Sapna Tibrewal; Yair Ivanir; Joy Sarkar; Neema Nayeb-Hashemi; Charles S Bouchard; Eunjae Kim; Sandeep Jain
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-18       Impact factor: 4.799

5.  Tear fluid extracellular DNA: diagnostic and therapeutic implications in dry eye disease.

Authors:  Sapna Tibrewal; Joy Sarkar; Sarmad H Jassim; Sonal Gandhi; Snehal Sonawane; Shweta Chaudhary; Yong-Soo Byun; Yair Ivanir; Joelle Hallak; John H Horner; Martin Newcomb; Sandeep Jain
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-11       Impact factor: 4.799

6.  Elevation of conjunctival epithelial CD45INTCD11b⁺CD16⁺CD14⁻ neutrophils in ocular Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Geraint P Williams; Paul J Tomlins; Alastair K Denniston; H Susan Southworth; Sreekanth Sreekantham; S John Curnow; Saaeha Rauz
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-10       Impact factor: 4.799

7.  Leukocyte Distribution in the Open Eye Tears of Normal and Dry Eye Subjects.

Authors:  Cameron K Postnikoff; Carrie Huisingh; Gerald McGwin; Kelly K Nichols
Journal:  Curr Eye Res       Date:  2018-08-09       Impact factor: 2.424

8.  The levels of 12 cytokines and growth factors in tears: hyperthyreosis vs euthyreosis.

Authors:  Jelena Juri Mandić; Ana Kozmar; Sanja Kusačić-Kuna; Anamarija Jazbec; Krešimir Mandić; Danijela Mrazovac; Nenad Vukojević
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-01-14       Impact factor: 3.117

Review 9.  The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research.

Authors:  Stephen C Pflugfelder; Cintia S de Paiva
Journal:  Ophthalmology       Date:  2017-11       Impact factor: 12.079

Review 10.  Cascade of Inflammatory, Fibrotic Processes, and Stress-Induced Senescence in Chronic GVHD-Related Dry Eye Disease.

Authors:  Yoko Ogawa; Yutaka Kawakami; Kazuo Tsubota
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.